RELMADA THERAPEUTICS, INC. (RLMD) Net income 2016–2025
RELMADA THERAPEUTICS, INC. (RLMD) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$57.4MFY2025 · since FY2016: -$6.3M → -$57.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$57.4M | +28.3% |
| FY2024 | -$80.0M | +19.0% |
| FY2023 | -$98.8M | +37.1% |
| FY2022 | -$157.0M | -24.9% |
| FY2021 | -$125.8M | -111.5% |
| FY2020 | -$59.5M | -296.2% |
| FY2019 | -$15.0M | +13.4% |
| FY2018 | -$17.3M | -93.3% |
| FY2017 | -$9.0M | -42.5% |
| FY2016 | -$6.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice